特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

コロナウイルス診断の世界市場:競合・予測・機会 - 検査タイプ(分子、血清)、ユーザー(単一・複数)、総所要時間、最終用途、地域別

Global Coronavirus Diagnostics Market, By Type of Test (Molecular v/s Serology), User (Single v/s Multiple), Full Test Time, End User, Region, Competition, Forecast & Opportunities, 2025

発行 TechSci Research 商品コード 932039
出版日 ページ情報 英文 115 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

コロナウイルス診断の世界市場:競合・予測・機会 - 検査タイプ(分子、血清)、ユーザー(単一・複数)、総所要時間、最終用途、地域別 Global Coronavirus Diagnostics Market, By Type of Test (Molecular v/s Serology), User (Single v/s Multiple), Full Test Time, End User, Region, Competition, Forecast & Opportunities, 2025
出版日: 2020年04月01日 ページ情報: 英文 115 Pages
概要

新型コロナウイルス感染症は、動物からヒトへ、ヒトからヒトへと感染が広がります。主な感染経路には飛沫感染や接触感染が挙げられます。初めての症例は2019年12月に中国の武漢で報告され、それ以来、世界各地に感染が広がり感染者数は数百万人にのぼっています。2020年4月9日までに確認された感染者数は150万人、回復者数は約33万人、死亡者数は8万8,000人となっています。世界のコロナウイルス診断市場は驚異的な成長率で推移しており、市場規模は2025年までに22億米ドルに達すると予測されています。新型コロナウイルス感染症の世界的な感染者の急増が当市場の成長を促進する要因となっています。

当レポートでは、世界のコロナウイルス診断市場を調査し、市場の概要、検査タイプ・ユーザー・総所要時間・最終用途・地域別の市場規模の推移と予測、市場の成長要因および課題、市場機会、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

  • ブランド認知度
  • 製品認知度
  • 顧客満足度の分析
  • 価格分析
  • アンメットニーズ/課題

第5章 世界のコロナウイルス診断市場の概要

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 検査タイプ別
      • 分子検査
      • 血清検査
    • ユーザー別
      • 単一
      • 複数
    • 総所要時間別
      • 60分未満
      • 1時間~12時間
      • 13時間~24時間
      • 1日以上
    • 最終用途別
      • 病院
      • 公衆衛生研究所
      • 民間研究所
      • 診療所
      • その他
    • 企業別
    • 地域別
  • 投与経路市場マップ

第6章 欧州のコロナウイルス診断市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • 最終用途別
    • 国別
  • 市場分析:国別
    • イタリア
    • スペイン
    • ドイツ
    • フランス
    • 英国

第7章 北米のコロナウイルス診断市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • 最終用途別
    • 国別
  • 市場分析:国別
    • 米国
    • カナダ
    • メキシコ

第8章 アジア太平洋地域のコロナウイルス診断市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • 最終用途別
    • 国別
  • 市場分析:国別
    • 中国
    • 韓国
    • オーストラリア
    • インド
    • 日本
    • タイ

第9章 中東・アフリカのコロナウイルス診断市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • 最終用途別
    • 国別
  • 市場分析:国別
    • イラン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ

第10章 南米のコロナウイルス診断市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • 最終用途別
    • 国別
  • 市場分析:国別
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 市場力学

  • 成長要因
  • 課題

第12章 市場動向

第13章 競合情勢

  • Roche Diagnostics
  • Abbott
  • Cepheid Inc
  • Bio-Rad Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Lonza
  • bioMerieux
  • Mammoth Biosciences
  • Hologic
  • Qiagen
  • GSK Biologicals
  • PerkinElmer
  • Ortho-Clinical Diagnostics
  • Thermo Fischer Scientific
  • Mylab
  • Altona Diagnostics

第14章 戦略的推奨事項

図表

List of Figures

  • Figure 1: Global Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 2: Global Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 3: Global Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 4: Global Coronavirus Diagnostics Market Share, By Full Test Time, 2020E-2025F
  • Figure 5: Global Coronavirus Diagnostics Market Share, By End - user, 2020E-2025F
  • Figure 6: Global Coronavirus Diagnostics Market Share, By Region, 2020E-2025F
  • Figure 7: Global Coronavirus Diagnostics Market Share, By Company, 2020E-2025F
  • Figure 8: Europe Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 9: Europe Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 10: Europe Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 11: Europe Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 12: Europe Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 13: Italy Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 14: Italy Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 15: Italy Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 16: Italy Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 17: Spain Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 18: Spain Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 19: Spain Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 20: Spain Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 21: Germany Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 22: Germany Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 23: Germany Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 24: Germany Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 25: France Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 26: France Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 27: France Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 28: France Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 29: United Kingdom Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 30: United Kingdom Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 31: United Kingdom Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 32: United Kingdom Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 33: North America Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 34: North America Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 35: North America Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 36: North America Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 37: North America Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 38: United States Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 39: United States Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 40: United States Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 41: United States Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 42: Canada Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 43: Canada Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 44: Canada Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 45: Canada Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 46: Mexico Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 47: Mexico Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 48: Mexico Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 49: Mexico Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 50: Asia-Pacific Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 51: Asia-Pacific Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 52: Asia-Pacific Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 53: Asia-Pacific Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 54: Asia-Pacific Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 55: China Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 56: China Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 57: China Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 58: China Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 59: South Korea Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 60: South Korea Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 61: South Korea Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 62: South Korea Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 63: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 64: Australia Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 65: Australia Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 66: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025
  • Figure 67: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 68: India Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 69: India Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 70: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025

Figure 71: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F

  • Figure 72: Japan Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 73: Japan Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 74: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 75: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 76: Thailand Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 77: Thailand Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 78: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 79: Middle East & Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 80: Middle East & Africa Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 81: Middle East & Africa Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 82: Middle East & Africa Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 83: Middle East & Africa Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 84: Iran Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 85: Iran Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 86: Iran Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 87: Iran Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 88: UAE Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 89: UAE Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 90: UAE Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 91: UAE Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 92: Saudi Arabia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 93: Saudi Arabia Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 94: Saudi Arabia Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 95: Saudi Arabia Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 96: South Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 97: South Africa Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 98: South Africa Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 99: South Africa Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 100: South America Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 101: South America Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 102: South America Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 103: South America Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 104: South America Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 105: Brazil Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 106: Brazil Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 107: Brazil Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 108: Brazil Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 109: Argentina Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 110: Argentina Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 111: Argentina Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 112: Argentina Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 113: Colombia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 114: Colombia Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 115: Colombia Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 116: Colombia Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
目次
Product Code: 4574

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 9th April 2020, the total number of coronavirus cases crossed 1.5 million, globally, of which around 330,000 had recovered and over 88,000 people had died.

Global coronavirus diagnostics market is expected to grow at a formidable rate and cross $ 2.2 billion by 2025. The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

Europe and North America are expected to witness significant growth during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include Roche Diagnostics, Abbott, Cepheid Inc, Bio-Rad Laboratories, Beckman Coulter, Becton, Dickinson and Company, Lonza, bioMerieux, Mammoth Biosciences, Hologic, Qiagen, GSK Biologicals, PerkinElmer, Ortho-Clinical Diagnostics, Thermo Fischer Scientific, Mylab, Altona Diagnostics and others.

Years considered for this report:

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To estimate and forecast the market size of global coronavirus diagnostics market from 2020 to 2025.
  • To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
  • To identify dominant regions and segments in the global coronavirus diagnostics market.
  • To identify drivers and challenges for global coronavirus diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
  • To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
  • To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to coronavirus diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type of Test:

Molecular

Serology

  • Market, By User:

Single

Multiple

  • Market, By Full Test Time:

Less Than 60 Minutes

1 Hour - 12 Hours

13 Hours - 24Hours

More Than 1 Day

  • Market, By End User:

Hospitals

Public Health Labs

Private or Commercial Labs

Physician Labs

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Iran

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness (Aided/Unaided)
  • 4.2. Product Awareness
  • 4.3. Customer Satisfaction Analysis
  • 4.4. Pricing Analysis
  • 4.5. Unmet Needs/Challenges

5. Global Coronavirus Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Test (Molecular v/s Serology)
    • 5.2.2. By User (Single v/s Multiple)
    • 5.2.3. By Full Test Time (Less Than 60 Minutes, 1 Hours to 12 Hours, 13 Hours-24Hours, More Than 1 Days)
    • 5.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
    • 5.2.5. By Company (2020)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Europe Coronavirus Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Test
    • 6.2.2. By User
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. Italy Coronavirus Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Test
        • 6.3.1.2.2. By User
        • 6.3.1.2.3. By End User
    • 6.3.2. Spain Coronavirus Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Test
        • 6.3.2.2.2. By User
        • 6.3.2.2.3. By End User
    • 6.3.3. Germany Coronavirus Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Test
        • 6.3.3.2.2. By User
        • 6.3.3.2.3. By End User
    • 6.3.4. France Coronavirus Diagnostics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type of Test
        • 6.3.4.2.2. By User
        • 6.3.4.2.3. By End User
    • 6.3.5. United Kingdom Coronavirus Diagnostics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type of Test
        • 6.3.5.2.2. By User
        • 6.3.5.2.3. By End User

7. North America Coronavirus Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Test
    • 7.2.2. By User
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Coronavirus Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Test
        • 7.3.1.2.2. By User
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Coronavirus Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Test
        • 7.3.2.2.2. By User
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Coronavirus Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Test
        • 7.3.3.2.2. By User
        • 7.3.3.2.3. By End User
        • 7.3.3.2.4.

8. Asia-Pacific Coronavirus Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Test
    • 8.2.2. By User
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Coronavirus Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Test
        • 8.3.1.2.2. By User
        • 8.3.1.2.3. By End User
    • 8.3.2. South Korea Coronavirus Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Test
        • 8.3.2.2.2. By User
        • 8.3.2.2.3. By End User
    • 8.3.3. Australia Coronavirus Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Test
        • 8.3.3.2.2. By User
        • 8.3.3.2.3. By End User
    • 8.3.4. India Coronavirus Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Test
        • 8.3.4.2.2. By User
        • 8.3.4.2.3. By End User
    • 8.3.5. Japan Coronavirus Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Test
        • 8.3.5.2.2. By User
        • 8.3.5.2.3. By End User
    • 8.3.6. Thailand Coronavirus Diagnostics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type of Test
        • 8.3.6.2.2. By User
        • 8.3.6.2.3. By End User

9. Middle East and Africa Coronavirus Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Test
    • 9.2.2. By User
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. Iran Coronavirus Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Test
        • 9.3.1.2.2. By User
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Coronavirus Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Test
        • 9.3.2.2.2. By User
        • 9.3.2.2.3. By End User
    • 9.3.3. Saudi Arabia Coronavirus Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Test
        • 9.3.3.2.2. By User
        • 9.3.3.2.3. By End User
    • 9.3.4. South Africa Coronavirus Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type of Test
        • 9.3.4.2.2. By User
        • 9.3.4.2.3. By End User

10. South America Coronavirus Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Test
    • 10.2.2. By User
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Coronavirus Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Test
        • 10.3.1.2.2. By User
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Coronavirus Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Test
        • 10.3.2.2.2. By User
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Coronavirus Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Test
        • 10.3.3.2.2. By User
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Roche Diagnostics
  • 13.2. Abbott
  • 13.3. Cepheid Inc
  • 13.4. Bio-Rad Laboratories
  • 13.5. Beckman Coulter
  • 13.6. Becton, Dickinson and Company
  • 13.7. Lonza
  • 13.8. bioMerieux
  • 13.9. Mammoth Biosciences
  • 13.10. Hologic
  • 13.11. Qiagen
  • 13.12. GSK Biologicals
  • 13.13. PerkinElmer
  • 13.14. Ortho-Clinical Diagnostics
  • 13.15. Thermo Fischer Scientific
  • 13.16. Mylab
  • 13.17. Altona Diagnostics

14. Strategic Recommendations